Astragaloside III

CAS: 84687-42-3

Ref. TR-A790135

Product Information

• Name: Astragaloside III
• Synonyms: β-D-Xylopyranoside, (3β,6α,16β,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-β-D-glucopyranosyl-, (3β,6α,16β,20R,24S)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-β-D-glucopyranosyl-β-D-xylopyranoside, (3beta,6alpha,9beta,16beta,20R,24S)-6,16,25-Trihydroxy-20,24-epoxy-9,19-cyclolanostan-3-yl 2-O-beta-D-glucopyranosyl-beta-D-xylopyranoside, (3β,6α,16β,20R,24S)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-xylopyranoside, beta-D-xylopyranoside, (3beta,6alpha,9beta,16beta,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-beta-D-glucopyranosyl-, β-<span class="text-smallcaps">D</smallcap>-Xylopyranoside, (3β,6α,16β,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-β-<smallcap>D</span>-glucopyranosyl-
• CAS: 84687-42-3

Description

Applications Astragaloside III has cardioprotective effects as well as causing improvement in cognitive function. Used in the prevention of cardio-cerebral vascular diseases. Antioxidant.
References Ye, G. et al.: Biomed. Cheom., 24, 1147 (2010); Lee, I. et al.: J. Food. Drug Anal., 20, 603 (2012); Shaw, L et al.: PLoS One, 7, e3848 (2012); Kong, X. et al.: Int. J. Mol. Med., 29, 1090 (2012);

• Brand: TRC

Chemical properties

• Molecular weight: 784.97
• Formula: C₄₁H₆₈O₁₄
• Color/Form: White to Off-White Solid
• InChI: InChI=1S/C41H68O14/c1-35(2)24(53-34-30(26(46)21(45)17-51-34)54-33-29(49)28(48)27(47)22(16-42)52-33)9-11-41-18-40(41)13-12-37(5)32(39(7)10-8-25(55-39)36(3,4)50)20(44)15-38(37,6)23(40)14-19(43)31(35)41/h19-34,42-50H,8-18H2,1-7H3/t19-,20-,21+,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34-,37+,38-,39+,40-,41+/m0/s1
• InChI key: InChIKey=SJUWEPZBTXEUMU-NUNOUFIPSA-N
• SMILES: Br.O=C(CC1NCCC[C@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O